Get the tools used by (smart)2 investors.

Gross Profit Margin for Organon & Co.

Join now and get access to the full platform

Search for company or ETF

 

  0 results available. Select is focused ,type to refine list, press Down to open the menu,

7XP: Organon & Co.

Organon & Co. develops and delivers health solutions through prescription therapies and medical devices in the United States, Europe, Canada, Japan, rest of the Asia Pacific, Latin America, the Middle...

9.77 EUR
Price
EUR
Fair Value
Upside
9.43 - 20.77
52-week range

Analysis

Fiscal Years
Trailing Twelve Months
Fiscal Halfs
Fiscal Quarters
Daily
Hide this widget

The following section summarizes insights on Organon & Co.'s Gross Profit Margin:

Dec 2016Dec 2018Dec 2020Dec 2022Dec 20240.0%20.0%40.0%60.0%80.0%

Performance Summary
  • Organon's latest twelve months gross profit margin is 58.0%
  • Organon's gross profit margin for fiscal years ending December 2020 to 2024 averaged 62.1%.
  • Organon's operated at median gross profit margin of 62.3% from fiscal years ending December 2020 to 2024.
  • Looking back at the last 5 years, Organon's gross profit margin peaked in December 2020 at 67.6%.
  • Organon's gross profit margin hit its 5-year low in December 2024 of 58.0%.
  • Organon's gross profit margin decreased in 2020 (67.6%, -4.5%), 2021 (62.3%, -7.7%), 2023 (59.8%, -4.9%), and 2024 (58.0%, -3.0%) and increased in 2022 (62.9%, +1.0%).

How does Organon's Gross Profit Margin benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Organon & Co. because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Metric Usage: Gross Profit Margin

Hide this widget
gp_margin
Slug
number
Datatype
text
Format
current
Default Period
FY, Q, LTM, YTD
Periods Supported
Free
Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Search for metric or datapoint

Gross Profit Margin

Gross profit expressed as a percent of revenue.

Definition of Gross Profit Margin

Hide this widget

The gross profit margin measures a company’s gross profit as a percentage of the revenue. The formula to calculate gross profit margin and an example calculation for Organon’s trailing twelve months is outlined below:

Gross Profit Margin  = Gross Profit / Total Revenue
58.0% = 3.586 B  /  6.181 B

The tables below summarizes Organon’s performance over the last five years:

Fiscal YearGross ProfitRevenueMargin
2020-12-313.612 B5.347 B67.6%
2021-12-313.452 B5.539 B62.3%
2022-12-313.628 B5.766 B62.9%
2023-12-313.395 B5.673 B59.8%
2024-12-313.586 B6.181 B58.0%

The tables below summarizes Organon’s performance over the last four quarters:

Quarter EndingGross ProfitRevenueMargin
2024-03-31886.9 M1.503 B59.0%
2024-06-30876.6 M1.5 B58.4%
2024-09-30828.9 M1.421 B58.3%
2024-12-31864.9 M1.537 B56.3%

You can read more about Gross Profit here.


Click the link below to download a spreadsheet with an example Gross Profit Margin calculation for Organon & Co. below:

Sector Benchmark Analysis

Sector
Industry Group
Industry
Hide this widget
-5,389.3%-3,889.3%-2,389.3%122.5%05001,0001,500

The chart above depicts the distribution of gross profit margin for companies operating in the Healthcare sector in the Developed economic region. Over 2,000 companies were considered in this analysis, and 1,946 had meaningful values. The average gross profit margin of companies in the sector is -29.5% with a standard deviation of 420.1%.

Organon & Co.'s Gross Profit Margin of 58.0% ranks in the 58.1% percentile for the sector. The following table provides additional summary stats:

Gross Profit Margin In The Healthcare Sector
Economic Risk RegionDeveloped
Total Constituents2,001
Included Constituents1,946
Min-5,295.6%
Max100.0%
Median50.2%
Mean-29.5%
Standard Deviation420.1%

You can find companies with similar gross profit margin using this stock screener.

All rights reserved. Terms Of Use